Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 609-271-5 | CAS number: 36609-29-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Remarks:
- The study on a similar substance serves as data source for the endpoint study record "CAPA 2043 Ames test: Riach, 2012 [TARGET]" and the justification for read-across is provided there.
- Adequacy of study:
- weight of evidence
- Study period:
- 7th March 2012 to 4th July 2012.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Study serves as data source; read-across justification is found in Target record.
Cross-reference
- Reason / purpose for cross-reference:
- read-across source
Reference
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Study period:
- 7th March 2012 to 4th July 2012.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- See attached justification
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- July 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Histidine and tryptophan
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- other:
- Remarks:
- All strains contain mutations in the histidine operon, imposing the essential requirement for histidine in the growth medium. Three mutations in the histidine operon are involved: his G 46 in TA 1535 and TA 100 his C 3076 in TA 1537 his D 3052 in TA 98
- Species / strain / cell type:
- E. coli WP2 uvr A
- Additional strain / cell type characteristics:
- other:
- Remarks:
- Ochre mutation in the trpE locus can be mutated to tryptophan-independence by a base-pair reversion of an A-T base-pair in the trpE locus, or more commonly, by a base-pair substitution within a number of transfer RNA loci elsewhere in the chromosome.
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix.
- Test concentrations with justification for top dose:
- The concentrations used in both the preliminary toxicity test and the mutation experiments were: 17, 50, 167, 500, 1667 and 5000 μg per plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- 2 μg per plate - TA 1535 and TA 1537, 0.5 μg per plate - TA 98 and TA 100 and 20 μg per plate - E. coli WP2uvrA
- Positive control substance:
- other: 2-Aminoanthracene
- Remarks:
- In the presence of S9 mix.
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Water
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- - with S. typhimurium TA 1535 and TA 100
- Positive control substance:
- sodium azide
- Remarks:
- In the absence of S9 mix.
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- 80 μg per plate - TA 1537
- Positive control substance:
- 9-aminoacridine
- Remarks:
- In the absence of S9 mix.
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- 1 μg per plate - TA 98
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- In the absence of S9 mix.
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- 2 μg per plate - E. coli WP2uvrA
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- In the absence of S9 mix.
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
In the first test, the direct plate incorporation test method was used. In the 2nd test, the Pre-incubation test was used.
For the toxicity tests, the plates were placed in an incubator set to maintain a temperature of 37°C for 2 days. The numbers of revertant colonies were noted and the plates carefully examined, microscopically, for thinning of the background lawn of microcolonies. Condition of background lawn was assessed as normal, slightly thin lawn (ST), thin lawn (TL), very thin lawn (VT) or lawn absent (A). Any precipitation of the test item on the plates was noted.
In the mutation tests, diluted agar was autoclaved and supplemented with sterile L-histidine.HCl (1.0 mM)/biotin (1.0 mM) was added at 50 mL per litre of soft agar for S. typhimurium. For E. coli, sterile L-tryptophan (1.35 mM) was added at 10 mL per litre of soft agar. These soft agars were thoroughly mixed and kept in a water bath set to maintain a temperature of 45°C.
In the first experiment using the direct plate incorporation method, soft agar (2 mL) was dispensed into a small plastic sterile tube. S9 mix or phosphate buffer (0.5 mL) was added, followed by the bacteria (0.1 mL) and, finally, the test solution. The tube contents (which were continually cooling) were mixed, then poured on to minimal medium plates prepared in-house. The plates contained BBL Purified Agar (1.5%, 20 mL) in Vogel-Bonner Medium E with glucose (2%, w/v).
In the second experiment using the pre-incubation method, S9 mix or phosphate buffer (0.5 mL) was dispensed into a small plastic sterile tube followed by the bacteria (0.1 mL) and, finally, the test solution. The tubes were then placed for 20 min in a shaking incubator set to maintain a temperature of 37°C. After incubation, soft agar (2 mL) was added to each tube. The tube contents were then mixed and poured onto minimal medium plates.
When the soft agar had set, the plates were inverted and placed in an incubator set to maintain a temperature of 37°C for 3 days and then examined. The numbers of mutant colonies on each plate were determined using a Colony Counter and captured electronically in a validated software system. The plates were also examined microscopically for precipitates and for microcolony growth.
NUMBER OF REPLICATIONS: Triplicate plates were used for each exposure level and bacterial strain in the presence and absence of metabolic activation. - Evaluation criteria:
- For S. typhimurium strains TA 1535, TA 1537, and TA 98 and for E. coli WP2uvrA, at least a doubling of the mean concurrent vehicle control value is required before mutagenic activity is suspected. For S. typhimurium strain TA 100, a 1.5-fold increase over the control value is required before mutagenic activity is suspected.
If the mean colony count on the vehicle control plates is less than 10, then a minimum count of 20 (representing a 2-fold increase over 10) is required before a response is registered.
A concentration-related response is also required for identification of a mutagenic effect. At high concentrations this relationship may be reversed because of, toxicity of the test item to the bacteria, specific toxicity of the test item to the mutants, or inhibition of S9 enzymes (where a mutagen requires metabolic activation by the S9 mix). A response should be reproducible in an independent test. - Statistics:
- The mean number of mutant colonies, plus standard deviation, was calculated for each set of 3 plates. In addition, the fold-increase over the vehicle control was calculated for all test item and positive control treatments.
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES:
In the toxicity tests, no toxicity to the bacteria was observed at any concentration in either the absence or the presence of S9 mix. At the highest concentration of 5000 μg per plate, precipitation was observed in the presence and absence of S9 mix.
In the mutation tests, for all bacterial strains tested, precipitation was observed at the highest concentration of 5000 μg per plate in the plate incorporation test, with and without metabolic activation. In the pre-incubation test method with and without metabolic activation, for strains TA1535, TA1537 and TA98, precipitation and a slight thinning of the background lawn was noted at the highest concentration tested (5000 μg per plate). For strains TA100 and e coli WP2 uvrA, precipitation was observed at this concentration level.
COMPARISON WITH HISTORICAL CONTROL DATA:
The vehicle and positive control values were within the normal/historical ranges recorded in this laboratory. - Conclusions:
- Under the conditions of this study, the read-across substance CAPA 2043 was not considered to be mutagenic when tested in the presence and absence of metabolic activation. A similar lack of mutagenic activity is therefore predicted for CAPA 2047A.
- Executive summary:
In a mutagenicity study conducted in accordance with GLP and OECD Guideline 471, the read-across substance CAPA 2043 (2 -oxepanone, polymer with 1,4 -butanediol) was tested in S. typhimurium and E. coli bacterial strains in the presence and absence of metabolic activation (S9 mix). The bacterial strains used were TA1535, TA1537, TA98 and TA100; and E. coli WP2uvrA. Two independent tests were conducted on agar plates in triplicate in the absence and presence of S9 mix, the first of which was conducted by the direct Plate Incorporation Method and the second test was conducted using the Pre-incubation Method, at concentrations of 17, 50, 167, 500, 1667 and 5000 μg per plate (the limit dose for this study). When CAPA 2043 was tested by the direct plate incorporation method, no cytotoxicity was observed. When tested by the pre-incubation method, cytotoxicity to the bacteria was observed as a slight thinning of the background lawn of microcolonies at the highest concentration of 5000 μg per plate. This observation was made in both the absence and the presence of S9 mix in strains TA 1535, TA 1537 and TA 98. CAPA 2043 precipitated at the highest concentration of 5000 μg per plate in all tests. There was no biologically relevant increase in the frequency of revertant colonies of any strain. Appropriate positive controls confirmed the sensitivity of the assay. Under the conditions of this study CAPA was not considered to be mutagenic when tested in the presence and absence of metabolic activation. A similar lack of mutagenic activity is therefore predicted for CAPA 2047A.
Summary of results
Mean revertant numbers |
||||||||||
Treatment |
EXPERIMENT 1 (PLATE INCORPORATION) |
|||||||||
TA98 |
TA100 |
TA1535 |
TA1537 |
WP2uvrA |
||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
|
DMSO |
25.7 |
25.0 |
83.3 |
91.7 |
12.7 |
15.7 |
10.3 |
14.7 |
11.0 |
9.7 |
17 µg |
20.7 |
26.7 |
105.7 |
83.3 |
8.7 |
11.7 |
7.7 |
8.7 |
7.0 |
9.0 |
50 µg |
25.3 |
36.3 |
86.3 |
76.0 |
9..7 |
8.7 |
14.0 |
11.3 |
8.3 |
9.0 |
167 µg |
32.7 |
31.7 |
103.3 |
85.3 |
14.7 |
12.3 |
9.0 |
10.7 |
7.0 |
9.0 |
500 µg |
23.7 |
22.0 |
91.3 |
73.3 |
13.7 |
13.3 |
9.78 |
11.7 |
8.0 |
8.3 |
1667 µg |
25.3 |
27.3 |
103.0 |
84.0 |
13.3 |
12.7 |
8.7 |
9.0 |
9.3 |
8.0 |
5000 µg |
21.3 |
31.3 |
90.0 |
85.3 |
16.0 |
15.7 |
9.3 |
18.7 |
11.7 |
5.7 |
2-NF |
521.3 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
NaN3 |
- |
- |
915.0 |
- |
377.7 |
- |
- |
- |
- |
- |
9AA |
- |
- |
- |
- |
- |
- |
4320 |
- |
- |
- |
ENNG |
- |
- |
- |
- |
- |
- |
- |
- |
96.3 |
- |
2AAN |
- |
307.7 |
- |
711.3 |
- |
313.0 |
- |
298.0 |
- |
729.3 |
Treatment |
EXPERIMENT 2 (PREINCUBATION) |
|||||||||
TA98 |
TA100 |
TA1535 |
TA1537 |
WP2uvrA |
||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
|
DMSO |
22.3 |
24.3 |
90.0 |
86.7 |
11.7 |
13.7 |
6.3 |
12.0 |
5.7 |
10.0 |
17 µg |
24.7 |
26.3 |
90.3 |
85.7 |
9.0 |
9.3 |
7.7 |
11.3 |
6.3 |
7.3 |
50 µg |
26.3 |
28.3 |
83.7 |
96.7 |
8.7 |
16.0 |
9.7 |
8.7 |
7.3 |
9.0 |
167 µg |
24.0 |
34.0 |
81.7 |
83.7 |
10.0 |
8.3 |
5.3 |
15.7 |
7.0 |
5.7 |
500 µg |
21.0 |
31.3 |
87.7 |
93.0 |
12.7 |
10.7 |
8.0 |
14.7 |
8.0 |
13.3 |
1667 µg |
19.7 |
26.3 |
89.7 |
88.3 |
10.0 |
13.3 |
7.7 |
14.3 |
7.0 |
11.3 |
5000 µg |
13.0 |
31.7 |
96.3 |
92.0 |
9.7 |
15.7 |
7.3 |
4.7 |
5.7 |
6.7 |
2-NF |
462.0 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
NaN3 |
- |
- |
1049 |
- |
368.7 |
- |
- |
- |
- |
- |
9AA |
- |
- |
- |
- |
- |
- |
5010 |
- |
- |
- |
ENNG |
- |
- |
- |
- |
- |
- |
- |
- |
407.0 |
- |
2AAN |
- |
332.3 |
- |
649.3 |
- |
230.3 |
- |
257.3 |
- |
812.3 |
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- July 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 2-Oxepanone, polymer with 1,4-butanediol
- Cas Number:
- 31831-53-5
- IUPAC Name:
- 2-Oxepanone, polymer with 1,4-butanediol
- Reference substance name:
- CAPA 2043
- IUPAC Name:
- CAPA 2043
- Reference substance name:
- Reference substance 001
- EC Number:
- 932-682-9
- Cas Number:
- 31831-53-5
- Reference substance name:
- 2-Oxepanone, polymer with 1,4-butanediol
- EC Number:
- 608-670-1
- Cas Number:
- 31831-53-5
- Molecular formula:
- l(HO(CH2)5CO)-O(CH2)4O-(CO(CH2)5OH)m
- IUPAC Name:
- 2-Oxepanone, polymer with 1,4-butanediol
- Test material form:
- other: liquid.
- Details on test material:
- - Name of test material (as cited in study report): Capa 2043
- Physical state: Colourless liquid.
- Analytical purity: 97%
- Lot/batch No.: WAC000392
- Expiration date of the lot/batch: 17th February 2014
- Storage condition of test material: Stored in the dark at room temperature.
Constituent 1
Constituent 2
Constituent 3
Constituent 4
- Specific details on test material used for the study:
- CAPA 2043 (2-oxepanone, polymer with 1,4-butanediol)
Method
- Target gene:
- Histidine and tryptophan
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- All S. typhimurium strains contain mutations in the histidine operon, thereby imposing the essential requirement for histidine in the growth medium. Three mutations in the histidine operon are involved:
his G 46 in TA 1535 and TA 100
his C 3076 in TA 1537
his D 3052 in TA 98 - Additional strain / cell type characteristics:
- not specified
- Species / strain / cell type:
- E. coli WP2 uvr A
- Details on mammalian cell type (if applicable):
- The strain contains an ochre mutation in the trpE locus and can be mutated to tryptophan-independence either by a base-pair reversion of an A-T base-pair in the trpE locus, or more commonly, by a base-pair substitution within a number of transfer RNA loci elsewhere in the chromosome. The latter mutation causes the original defect to be suppressed (ochre suppression) and involves only base-pair substitutions at G-C base-pairs.
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix.
- Test concentrations with justification for top dose:
- The concentrations used in both the preliminary toxicity test and the mutation experiments were: 17, 50, 167, 500, 1667 and 5000 μg per plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
Controlsopen allclose all
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- 2 μg per plate - TA 1535 and TA 1537, 0.5 μg per plate - TA 98 and TA 100 and 20 μg per plate - E. coli WP2uvrA
- Positive control substance:
- other: 2-Aminoanthracene
- Remarks:
- In the presence of S9 mix.
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Water
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- - with S. typhimurium TA 1535 and TA 100
- Positive control substance:
- sodium azide
- Remarks:
- In the absence of S9 mix.
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- 80 μg per plate - TA 1537
- Positive control substance:
- 9-aminoacridine
- Remarks:
- In the absence of S9 mix.
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- 1 μg per plate - TA 98
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- In the absence of S9 mix.
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- 2 μg per plate - E. coli WP2uvrA
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- In the absence of S9 mix.
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
In the first test, the direct plate incorporation test method was used. In the 2nd test, the Pre-incubation test was used.
For the toxicity tests, the plates were placed in an incubator set to maintain a temperature of 37°C for 2 days. The numbers of revertant colonies were noted and the plates carefully examined, microscopically, for thinning of the background lawn of microcolonies. Condition of background lawn was assessed as normal, slightly thin lawn (ST), thin lawn (TL), very thin lawn (VT) or lawn absent (A). Any precipitation of the test item on the plates was noted.
In the mutation tests, diluted agar was autoclaved and supplemented with sterile L-histidine.HCl (1.0 mM)/biotin (1.0 mM) was added at 50 mL per litre of soft agar for S. typhimurium. For E. coli, sterile L-tryptophan (1.35 mM) was added at 10 mL per litre of soft agar. These soft agars were thoroughly mixed and kept in a water bath set to maintain a temperature of 45°C.
In the first experiment using the direct plate incorporation method, soft agar (2 mL) was dispensed into a small plastic sterile tube. S9 mix or phosphate buffer (0.5 mL) was added, followed by the bacteria (0.1 mL) and, finally, the test solution. The tube contents (which were continually cooling) were mixed, then poured on to minimal medium plates prepared in-house. The plates contained BBL Purified Agar (1.5%, 20 mL) in Vogel-Bonner Medium E with glucose (2%, w/v).
In the second experiment using the pre-incubation method, S9 mix or phosphate buffer (0.5 mL) was dispensed into a small plastic sterile tube followed by the bacteria (0.1 mL) and, finally, the test solution. The tubes were then placed for 20 min in a shaking incubator set to maintain a temperature of 37°C. After incubation, soft agar (2 mL) was added to each tube. The tube contents were then mixed and poured onto minimal medium plates.
When the soft agar had set, the plates were inverted and placed in an incubator set to maintain a temperature of 37°C for 3 days and then examined. The numbers of mutant colonies on each plate were determined using a Colony Counter and captured electronically in a validated software system. The plates were also examined microscopically for precipitates and for microcolony growth.
NUMBER OF REPLICATIONS: Triplicate plates were used for each exposure level and bacterial strain in the presence and absence of metabolic activation. - Evaluation criteria:
- For S. typhimurium strains TA 1535, TA 1537, and TA 98 and for E. coli WP2uvrA, at least a doubling of the mean concurrent vehicle control value is required before mutagenic activity is suspected. For S. typhimurium strain TA 100, a 1.5-fold increase over the control value is required before mutagenic activity is suspected.
If the mean colony count on the vehicle control plates is less than 10, then a minimum count of 20 (representing a 2-fold increase over 10) is required before a response is registered.
A concentration-related response is also required for identification of a mutagenic effect. At high concentrations this relationship may be reversed because of, toxicity of the test item to the bacteria, specific toxicity of the test item to the mutants, or inhibition of S9 enzymes (where a mutagen requires metabolic activation by the S9 mix). A response should be reproducible in an independent test. - Statistics:
- The mean number of mutant colonies, plus standard deviation, was calculated for each set of 3 plates. In addition, the fold-increase over the vehicle control was calculated for all test item and positive control treatments.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES:
In the toxicity tests, no toxicity to the bacteria was observed at any concentration in either the absence or the presence of S9 mix. At the highest concentration of 5000 μg per plate, precipitation was observed in the presence and absence of S9 mix.
In the mutation tests, for all bacterial strains tested, precipitation was observed at the highest concentration of 5000 μg per plate in the plate incorporation test, with and without metabolic activation. In the pre-incubation test method with and without metabolic activation, for strains TA1535, TA1537 and TA98, precipitation and a slight thinning of the background lawn was noted at the highest concentration tested (5000 μg per plate). For strains TA100 and e coli WP2 uvrA, precipitation was observed at this concentration level.
COMPARISON WITH HISTORICAL CONTROL DATA:
The vehicle and positive control values were within the normal/historical ranges recorded in this laboratory.
Any other information on results incl. tables
Summary of results
Mean revertant numbers |
||||||||||
Treatment |
EXPERIMENT 1 (PLATE INCORPORATION) |
|||||||||
TA98 |
TA100 |
TA1535 |
TA1537 |
WP2uvrA |
||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
|
DMSO |
25.7 |
25.0 |
83.3 |
91.7 |
12.7 |
15.7 |
10.3 |
14.7 |
11.0 |
9.7 |
17 µg |
20.7 |
26.7 |
105.7 |
83.3 |
8.7 |
11.7 |
7.7 |
8.7 |
7.0 |
9.0 |
50 µg |
25.3 |
36.3 |
86.3 |
76.0 |
9..7 |
8.7 |
14.0 |
11.3 |
8.3 |
9.0 |
167 µg |
32.7 |
31.7 |
103.3 |
85.3 |
14.7 |
12.3 |
9.0 |
10.7 |
7.0 |
9.0 |
500 µg |
23.7 |
22.0 |
91.3 |
73.3 |
13.7 |
13.3 |
9.78 |
11.7 |
8.0 |
8.3 |
1667 µg |
25.3 |
27.3 |
103.0 |
84.0 |
13.3 |
12.7 |
8.7 |
9.0 |
9.3 |
8.0 |
5000 µg |
21.3 |
31.3 |
90.0 |
85.3 |
16.0 |
15.7 |
9.3 |
18.7 |
11.7 |
5.7 |
2-NF |
521.3 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
NaN3 |
- |
- |
915.0 |
- |
377.7 |
- |
- |
- |
- |
- |
9AA |
- |
- |
- |
- |
- |
- |
4320 |
- |
- |
- |
ENNG |
- |
- |
- |
- |
- |
- |
- |
- |
96.3 |
- |
2AAN |
- |
307.7 |
- |
711.3 |
- |
313.0 |
- |
298.0 |
- |
729.3 |
Treatment |
EXPERIMENT 2 (PREINCUBATION) |
|||||||||
TA98 |
TA100 |
TA1535 |
TA1537 |
WP2uvrA |
||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
|
DMSO |
22.3 |
24.3 |
90.0 |
86.7 |
11.7 |
13.7 |
6.3 |
12.0 |
5.7 |
10.0 |
17 µg |
24.7 |
26.3 |
90.3 |
85.7 |
9.0 |
9.3 |
7.7 |
11.3 |
6.3 |
7.3 |
50 µg |
26.3 |
28.3 |
83.7 |
96.7 |
8.7 |
16.0 |
9.7 |
8.7 |
7.3 |
9.0 |
167 µg |
24.0 |
34.0 |
81.7 |
83.7 |
10.0 |
8.3 |
5.3 |
15.7 |
7.0 |
5.7 |
500 µg |
21.0 |
31.3 |
87.7 |
93.0 |
12.7 |
10.7 |
8.0 |
14.7 |
8.0 |
13.3 |
1667 µg |
19.7 |
26.3 |
89.7 |
88.3 |
10.0 |
13.3 |
7.7 |
14.3 |
7.0 |
11.3 |
5000 µg |
13.0 |
31.7 |
96.3 |
92.0 |
9.7 |
15.7 |
7.3 |
4.7 |
5.7 |
6.7 |
2-NF |
462.0 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
NaN3 |
- |
- |
1049 |
- |
368.7 |
- |
- |
- |
- |
- |
9AA |
- |
- |
- |
- |
- |
- |
5010 |
- |
- |
- |
ENNG |
- |
- |
- |
- |
- |
- |
- |
- |
407.0 |
- |
2AAN |
- |
332.3 |
- |
649.3 |
- |
230.3 |
- |
257.3 |
- |
812.3 |
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of this study, the test material Capa 2043, was not considered to be mutagenic when tested in the presence and absence of metabolic activation.
- Executive summary:
In a mutagenicity study conducted in accordance with GLP and OECD Guideline 471, CAPA 2043 (2 -oxepanone, polymer with 1,4 -butanediol) was tested in S. typhimurium and E. coli bacterial strains in the presence and absence of metabolic activation (S9 mix). The bacterial strains used were TA1535, TA1537, TA98 and TA100; and E. coli WP2uvrA. Two independent tests were conducted on agar plates in triplicate in the absence and presence of S9 mix, the first of which was conducted by the direct Plate Incorporation Method and the second test was conducted using the Pre-incubation Method, at concentrations of 17, 50, 167, 500, 1667 and 5000 μg per plate (the limit dose for this study). When CAPA 2043 was tested by the direct plate incorporation method, no cytotoxicity was observed. When tested by the pre-incubation method, cytotoxicity to the bacteria was observed as a slight thinning of the background lawn of microcolonies at the highest concentration of 5000 μg per plate. This observation was made in both the absence and the presence of S9 mix in strains TA 1535, TA 1537 and TA 98. CAPA 2043 precipitated at the highest concentration of 5000 μg per plate in all tests. There was no biologically relevant increase in the frequency of revertant colonies of any strain. Appropriate positive controls confirmed the sensitivity of the assay. Under the conditions of this study CAPA was not considered to be mutagenic when tested in the presence and absence of metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)